Coherence Neuro

Coherence Neuro is a therapeutic neurotechnology company pioneering bioelectronic cancer therapy. The company is developing implantable brain-computer interface devices that both monitor and treat cancers — including glioblastoma, triple-negative breast cancer, and pancreatic cancer — by reading and modulating the body's electrical signals in real time. Its flagship device, SOMA-1, is a minimally invasive, MRI-safe implant that delivers closed-loop bioelectronic stimulation directly to tumor tissue while continuously recording electrophysiological data to enable AI-driven adaptive therapy. Coherence is building the world's first bi-directional electrotherapy platform that acts as cancer therapy, diagnostics, and a continuously learning model simultaneously.